Skip to content

I&L Biosystems Belgium

Active Private limited companyfounded 2020active for 6 yearsMartelarenplein 20, 3000 LeuvenKBO/BCE: BE 0758.457.450

Lifetime

5 annual accounts with figures on one time axis
peak of €248,230 in 2024
€213,144▼ 14.1%
peak of €80,070 in 2022
€30,584▲ 190%
peak of €209,260 in 2023
€150,381▲ 25.5%
€426,501▲ 24.8%
peak of 1.5 FTE in 2024
1.3 FTE▼ 13.3%
Board5 names since 2020
2 directors and 1 other
Documentsfilings and deeds
31-08-202631 days late
2025abbreviated format
Gross margin from €248,230 to €213,144Result from €10,537 to €30,584Staff from 1.5 FTE to 1.3 FTEEquity from €119,798 to €150,381Debts from €341,717 to €426,501

Key points

from the 2025 annual accounts

Equity

€150,381 ▲ 25.5%

I&L Biosystems Belgium has made a profit in every financial year since 2021.

Debts

€426,501 74% of the balance sheet
Suppliers 83%Taxes and wages 17%

Of this, €424,031 falls due within a year.

Staff

1 employees on 31-12-2025
202023002024012025

In 2025, nobody joined and 1 employee left.

Filings

5 annual accounts 3 late
AprilJune31 JulyOctober20222024

The 2025 accounts came in latest, 31 days after the end of the period.

Board

1 left

A director left. Latest change 21-08-2026 · 1 in office.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,715 companies had the same profile as I&L Biosystems Belgium has now. Each dot stands for 17 companies, two years later.

95.8%
were still trading
2.2%
stopped another way
1.8%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,715 companies, not a prediction for I&L Biosystems Belgium. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 25-02-2024
  • 100 sharesdeed of 18-11-2020
Board & ownership

Recent changes

resigns as director General meeting of 03-09-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0758457450
2 directors appointed, 2 resignations and resign · and appointed · Director discharge: · General meeting of 19-07-2024 · Gazette deed
Incorporation Founding capital of €25,000, 100 shares · Founded by · (director) and (director) appointed · published on 18-11-2020 · Gazette deed
All 14 events

Comparable companies

same main activity, similar in size and age
Company
I&L Biosystems Belgium Leuven €576,883 €213,144 26.1% 1.3
Medsupplies Oudenaarde €743,904 €284,850 45.5% 1
Mobimed Roeselare €600,671 €384,166 61.7% 1
MEDA BRIGHT Brussels €469,972 €223,043 22.7% 1
Ortho4Vets Tielt €448,280 €224,925 18.0% 0.5
HYGEMED Mons €570,164 €194,123 55.8% 1.7
AllweCare Belgium Aarschot €286,506 €134,720 -49.5% 1

These companies have the same main activity as I&L Biosystems Belgium: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €287,000 and €744,000, founded between 2018 and 2022.

Official details

Source: KBO
Status
Active since 16-11-2020Normal situation
Registered office
44 active companies are registered at this address1 started in the 12 months before. Source: KBO register, as of 18 November 2026.
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Joint committees
116Chemical industry
207White-collar workers in the chemical industry · annual accounts 2024
Establishment unit
2.317.621.6913000 Leuven, since 16-11-2020
Financial year end
31 December
Peppol
Reachable since 09-06-2026
Company details

Annual accounts 2025

≈ €1.1mestimated
€576,883▲ 25.0%
Employeeson 31-12-2025
1▼ 50.0%
Filing
Filed on 31-08-2026
Financials

Insights on I&L Biosystems Belgium

I&L Biosystems Belgium files the abbreviated format. That format states no turnover. The gross margin rose from €52,233 in 2021 to €213,144 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about I&L Biosystems Belgium

What is the company number of I&L Biosystems Belgium?
The company number of I&L Biosystems Belgium is 0758.457.450. The VAT number is the same number with BE in front: BE 0758.457.450.
Where is I&L Biosystems Belgium based?
The registered office is at Martelarenplein 20, 3000 Leuven.Company details
What does I&L Biosystems Belgium do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of I&L Biosystems Belgium?
I&L Biosystems Belgium is a private limited company (BV).
When was I&L Biosystems Belgium founded?
I&L Biosystems Belgium was founded on 16-11-2020.
Is I&L Biosystems Belgium still active?
Yes, I&L Biosystems Belgium is an active enterprise in the KBO register.
How many employees does I&L Biosystems Belgium have?
I&L Biosystems Belgium had an average of 1.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does I&L Biosystems Belgium fall under?
In its 2024 annual accounts, I&L Biosystems Belgium states joint committees 116 (Chemical industry) and 207 (White-collar workers in the chemical industry).
What is the turnover of I&L Biosystems Belgium?
The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €213,144 and 86 comparable companies (NACE 46). It probably lies between €510,000 and €2.0m.
Is I&L Biosystems Belgium profitable?
In financial year 2025, I&L Biosystems Belgium made a profit of €30,584.
Where can I find the annual accounts of I&L Biosystems Belgium?
I&L Biosystems Belgium filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of I&L Biosystems Belgium due?
I&L Biosystems Belgium must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.